Physician profile
Jeffery P Schoonover
NPI 1245205293
$48,294.48
in general payments reported to CMS, 2019-2025
15 companies · $6,026 in 2025
The $6,026 reported for 2025 was more than what 97% of Phlebology providers received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $10K · 2021: $2,408 · 2022: $3,936 · 2023: $3,154 · 2024: $11K · 2025: $6,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,213 · Long Term Medical Supply Or Device Loan: $7,200 · Food and Beverage: $1,944 · Travel and Lodging: $1,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,212.50 |
| Long Term Medical Supply Or Device Loan | $7,200.00 |
| Food and Beverage | $1,944.46 |
| Travel and Lodging | $1,712.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $32,568.52 | 2019-2025 | Venacure 1470 Pro |
| Tactile Systems Technology INC | $13,193.79 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Bard Peripheral Vascular, INC. | $1,096.10 | 2021-2025 | Venclose Maven Catheter |
| Boston Scientific Corporation | $698.71 | 2020-2024 | Varithena Administration Pack |
| Medtronic, INC. | $187.36 | 2022-2025 | Venaseal, Closurefast |
| Medtronic Vascular, INC. | $134.73 | 2019 | |
| Abbott Laboratories | $83.34 | 2025 | Esprit |
| Pfizer INC. | $81.94 | 2021-2023 | |
| Venclose INC. | $67.75 | 2020 | |
| Merz North America, INC. | $62.35 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $51.78 | 2021-2022 | |
| Kerecis Limited | $21.67 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Biocompatibles, INC. | $18.29 | 2019 | |
| Medline Industries Lp | $14.54 | 2022 | |
| Teleflex LLC | $13.61 | 2025 | Arrow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Schoonover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.